NeuroSense Reports First Quarter 2023 Financial Results & Pr

/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...

Related Keywords

Massachusetts , United States , Cambridge , Cambridgeshire , United Kingdom , Ghazaleh Sadri Vakili , Linkedin , Hospital Neuroepigenetics Lab , Neurosense Therapeutics Ltd , Prnewswire Neurosense Therapeutics Ltd , Twitter , Nasdaq , Sense Therapeutics , Patient Enrollment , Participants Who Completed , Trial Chose , Trial Under Preparation , Massachusetts General Hospital , Neuroepigenetics Lab , Improve Early Detection , Interim Unaudited Consolidated Statements , Neurosense ,